News Medical on MSN4h
Study explores the impact of respiratory bacteria on RSV severity
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...
clinicaltrialsarena3d
Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
Virus spreading in China raises concerns in the United States
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
The lesser-known winter virus that is different to flu and Covid but just as dangerous
Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...
GlobalData on MSN7d
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
The Stanly News and Press1d
Seasonal respiratory illnesses surge in N.C.
The North Carolina Department of Health and Human Services on Wednesday updated its weekly Respiratory Virus Summary Dashboard, which shows an increase in flu activity and flu-related deaths, bringing ...
Iredell Free News1d
N.C. health officials report surge in seasonal respiratory illnesses across state
RALEIGH — The N.C. Department of Health and Human Services on Wednesday reported an increase in flu activity and flu-related deaths, bringing the total number of deaths this season to 117.
hVIVO wins contract for RSV drug human trial for Inhalon Biopharma
(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...